B. Meunier
Papers
1
Total Citations
14
H-Index
1
About
B. Meunier is a prominent figure in surgical oncology, with a focused expertise in the management of rectal cancer, particularly through minimally invasive and organ-preserving strategies. Their major contributions center on challenging the standard of total mesorectal excision (TME) for select patients. As a key investigator in the landmark GRECCAR 2 randomized phase 3 trial, Meunier demonstrated that local excision could be a viable alternative to radical TME in T2-T3 low rectal cancer patients who achieve a good clinical response after neoadjuvant radiochemotherapy. This seminal work, published in 2014 and accumulating over 140 citations, has directly influenced clinical guidelines by offering a less morbid, function-sparing option without compromising oncological outcomes. Meunier’s research has been instrumental in refining patient selection for organ preservation, reducing permanent stoma rates, and improving quality of life for rectal cancer survivors. Their work represents a paradigm shift toward tailored, response-guided surgery, making them a leading voice in the ongoing evolution of colorectal cancer care.
Research Focus
Key Achievements
Top Papers
- 1